×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ROIV – roivant sciences ltd. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ROIV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
09:00 am
roiv
Roivant Sciences (ROIV) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $35.00 price target on the stock.
Low
Report
Roivant Sciences (ROIV) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $35.00 price target on the stock.
3/20
08:29 am
roiv
REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD [Yahoo! Finance]
Low
Report
REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD [Yahoo! Finance]
3/4
03:32 pm
roiv
A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength [Yahoo! Finance]
Low
Report
A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength [Yahoo! Finance]
3/4
09:03 am
roiv
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by TD Cowen.
3/4
08:39 am
roiv
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance]
Low
Report
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance]
3/4
08:38 am
roiv
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance Canada]
Low
Report
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance Canada]
3/4
08:00 am
roiv
Roivant Sciences (ROIV) had its price target raised by HC Wainwright from $33.00 to $34.00. They now have a "buy" rating on the stock.
Medium
Report
Roivant Sciences (ROIV) had its price target raised by HC Wainwright from $33.00 to $34.00. They now have a "buy" rating on the stock.
3/4
05:34 am
roiv
What Roivant Sciences (ROIV)'s Priority FDA Review for Brepocitinib in Dermatomyositis Means For Shareholders [Yahoo! Finance]
Medium
Report
What Roivant Sciences (ROIV)'s Priority FDA Review for Brepocitinib in Dermatomyositis Means For Shareholders [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
01:02 pm
roiv
Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: VANGUARD GROUP INC
3/26
04:15 pm
roiv
Form 144 Roivant Sciences Ltd. Filed by: Fitzgerald Meghan
Medium
Report
Form 144 Roivant Sciences Ltd. Filed by: Fitzgerald Meghan
3/24
07:09 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Pulik Richard
Low
Report
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Pulik Richard
3/24
07:08 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Humes Jennifer
Low
Report
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Humes Jennifer
3/23
08:44 am
roiv
Form 8-K/A Roivant Sciences Ltd. For: Mar 03
Low
Report
Form 8-K/A Roivant Sciences Ltd. For: Mar 03
3/19
06:37 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 17 Filed by: Venker Eric
Low
Report
Form 4 Roivant Sciences Ltd. For: Mar 17 Filed by: Venker Eric
3/18
06:23 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 16 Filed by: Epperly Melissa B,
Neutral
Report
Form 4 Roivant Sciences Ltd. For: Mar 16 Filed by: Epperly Melissa B,
3/17
04:18 pm
roiv
Form 144 Roivant Sciences Ltd. Filed by: Venker Eric
Low
Report
Form 144 Roivant Sciences Ltd. Filed by: Venker Eric
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: